Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Johnson and Johnson
UBS
Argus Health
McKesson
Citi
Cantor Fitzgerald
Fuji
Teva
Accenture

Generated: August 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075191

« Back to Dashboard
NDA 075191 describes PENTOXIFYLLINE, which is a drug marketed by Watson Labs, Mylan, Valeant Pharms, Pliva, Heritage Pharms Inc, Actavis Elizabeth, Apotex, Impax Labs, and Teva, and is included in nine NDAs. It is available from twenty-one suppliers. Additional details are available on the PENTOXIFYLLINE profile page.

The generic ingredient in PENTOXIFYLLINE is pentoxifylline. There are fourteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.

Summary for NDA: 075191

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 075191

Suppliers and Packaging for NDA: 075191

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PENTOXIFYLLINE
pentoxifylline
TABLET, EXTENDED RELEASE;ORAL 075191 ANDA Major Pharmaceuticals 0904-5448 0904-5448-61 100 BLISTER PACK in 1 CARTON (0904-5448-61) > 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
PENTOXIFYLLINE
pentoxifylline
TABLET, EXTENDED RELEASE;ORAL 075191 ANDA Aidarex Pharmaceuticals LLC 33261-992 33261-992-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (33261-992-30)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength400MG
Approval Date:Jun 9, 1999TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Healthtrust
Cerilliant
Deloitte
Novartis
Boehringer Ingelheim
AstraZeneca
McKinsey
McKesson
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot